ArticleFrontiers in pharmacology2023

I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition.

Congying Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.